camptothecin has been researched along with mechlorethamine in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 6 (85.71) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Caldecott, K; Jeggo, P | 1 |
Kann, HE; Kohn, KW | 1 |
Kohn, KW; O'Connor, PM; Pommier, Y; Shimizu, T | 1 |
Bohr, VA; Stevnsner, T | 1 |
Hockenbery, D; Kohn, KW; Korsmeyer, SJ; O'Connor, PM; Walton, MI; Whysong, D | 1 |
Bhatia, U; Darzynkiewicz, Z; Traganos, F | 1 |
Hwang, A; Janss, A; Maity, A; McKenna, WG; Muschel, RJ; Phillips, P | 1 |
7 other study(ies) available for camptothecin and mechlorethamine
Article | Year |
---|---|
Cross-sensitivity of gamma-ray-sensitive hamster mutants to cross-linking agents.
Topics: Animals; Camptothecin; Cell Line; Cell Survival; CHO Cells; Cisplatin; Cricetinae; Cricetulus; Cross-Linking Reagents; DNA Damage; Female; Guinea Pigs; Mechlorethamine; Melphalan; Mitomycin; Mutation; Radiation Tolerance; Ultraviolet Rays | 1991 |
Effects of deoxyribonucleic acid-reactive drugs on ribonucleic acid synthesis in leukemia L1210 cells.
Topics: Acridines; Acrylamides; Alkaloids; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Benzazepines; Camptothecin; Carbazoles; Carbon Isotopes; Cell Nucleolus; Cell Nucleus; Centrifugation, Density Gradient; Dactinomycin; Daunorubicin; Deoxyadenosines; DNA, Neoplasm; Ethidium; Leukemia L1210; Mechlorethamine; Methionine; Phenanthridines; Pyridines; Pyrroles; RNA, Neoplasm; Tritium; Uridine | 1972 |
Unscheduled activation of cyclin B1/Cdc2 kinase in human promyelocytic leukemia cell line HL60 cells undergoing apoptosis induced by DNA damage.
Topics: Aphidicolin; Apoptosis; Camptothecin; CDC2 Protein Kinase; Cyclins; DNA Damage; Enzyme Activation; Etoposide; Humans; Leukemia, Promyelocytic, Acute; Mechlorethamine; Phosphorylation; S Phase; Tumor Cells, Cultured | 1995 |
Studies on the role of topoisomerases in general, gene- and strand-specific DNA repair.
Topics: Animals; Camptothecin; CHO Cells; Cisplatin; Cricetinae; DNA Repair; DNA Replication; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Mechlorethamine; Pyrimidine Dimers; RNA, Messenger; Tetrahydrofolate Dehydrogenase; Thiobarbiturates; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 1993 |
Constitutive expression of human Bcl-2 modulates nitrogen mustard and camptothecin induced apoptosis.
Topics: Animals; Apoptosis; Camptothecin; Cell Cycle; Cell Line; DNA Damage; Drug Resistance; Gene Expression; Humans; Interleukin-3; Mechlorethamine; Mice; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogenes | 1993 |
Induction of cell differentiation potentiates apoptosis triggered by prior exposure to DNA-damaging drugs.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Apoptosis; Azacitidine; Butyrates; Butyric Acid; Camptothecin; Cell Differentiation; DNA Damage; Enzyme Inhibitors; Humans; Mechlorethamine; Topoisomerase I Inhibitors; Tumor Cells, Cultured | 1995 |
Delayed cyclin B1 expression during the G2 arrest following DNA damage.
Topics: Antineoplastic Agents; Camptothecin; Cyclin B; Cyclin B1; Cyclins; DNA Damage; Etoposide; G2 Phase; Gene Expression Regulation; HeLa Cells; Humans; Mechlorethamine; Promoter Regions, Genetic; RNA, Messenger | 1996 |